Pediatric Verrucous Psoriasis: A Case Report in a Pediatric Patient
Verrucous psoriasis (VP) is a rare histologic variant of psoriasis. To date, fewer than 40 cases have been reported, with pediatric cases representing an exceedingly small fraction. Treatment options are limited, and the disease is often refractory to conventional methods. Herein, JDD authors Samantha Sherkin OMS-IV, Christian Summa OMS-IV, David Crasto DO, Zackary Whitney DO, Lazlo Karai MD PhD,� …
Verrucous psoriasis (VP) is a rare histologic variant of psoriasis. To date, fewer than 40 cases have been reported, with pediatric cases representing an exceedingly small fraction. Treatment options are limited, and the disease is often refractory to conventional methods. Herein, JDD authors Samantha Sherkin OMS-IV, Christian Summa OMS-IV, David Crasto DO, Zackary Whitney DO, Lazlo Karai MD PhD,� … Continue reading "Pediatric Verrucous Psoriasis: A Case Report in a Pediatric Patient"
Linda Stein Gold, Director of Dermatology Clinical Research at Henry Ford Health System, lead us through “Acne across the ages” at the 17th Annual Women’s and Pediatric Dermatology Seminar. She busted through several acne myths, which are easily debunked with new acne medications:
Clascoterone 1% cream: it reduces sebum production in the skin! Similar to spironolactone, it is an anti-andr … 
The August issue of the Journal of Drugs in Dermatology (JDD) focuses on Psoriasis and features mix of original articles, editorials, and case reports. Among many of the topics explored in this issue are treatment of scalp psoriasis, nail psoriasis, respiratory tract infections in patients using biologics for hidradenitis suppurativa, classification of actinic keratosis, lichen planus pigmentosus … 
Our new series, “The Many Faces of”, showcases side-by-side images of some of the most commonly seen dermatology conditions in an array of skin tones and briefly highlight nuances in clinical presentation. All images featured in the series are part of The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas, a resource developed by co-editors Misty Eleryan, MD, MS, and Adam Friedman, … 
Botulinum toxin is a safe and potentially effective treatment alternative in hidradenitis suppurativa (HS) patients who are resistant to standard therapies, according to the authors of a systematic review published in the Journal of Drugs in Dermatology.
How does this review add to the conversation about new treatments for HS? In which HS patients might dermatologists consider botulinum toxin as … 